Cagrilintide is an investigational amylin analog peptide developed to complement GLP-1 receptor agonists like semaglutide and tirzepatide
Measurement of liver function Serum ALT, AST and alkaline phosphate activities, as well as bilirubin levels were determined by using an Olympus AU5400 Automatic Biochemical Analyzer (Olympus, Tokyo, Japan) in the Department of Inspection, The First Affiliated Hospital of Xi'an Jiaotong University 26
5,6 We did not evaluate the impact of discontinuing semaglutide or the potential side effects reported in previous trials, which include an elevated risk of developing thyroid cancer, gallbladder-related disorders, or gastrointestinal disorders
That's a lot to manage while also living your life
The medication may make these problems worse
Important: B12 injections are not intended to diagnose, treat, cure, or prevent disease